- Report
- October 2024
- 70 Pages
India
From €840EUR$950USD£717GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €840EUR$950USD£717GBP
- Report
- October 2024
- 70 Pages
China
From €840EUR$950USD£717GBP
- Report
- October 2024
- 70 Pages
France
From €840EUR$950USD£717GBP
- Report
- October 2024
- 70 Pages
Germany
From €840EUR$950USD£717GBP
- Report
- October 2024
- 70 Pages
India
From €840EUR$950USD£717GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €840EUR$950USD£717GBP
- Report
- November 2023
- 76 Pages
Global
From €3979EUR$4,500USD£3,395GBP
- Report
- February 2023
- 183 Pages
From €3050EUR$3,450USD£2,603GBP
- Report
- November 2022
- 150 Pages
Global
From €4288EUR$4,850USD£3,659GBP
- Database
- December 2021
United States
From €2210EUR$2,500USD£1,886GBP
- Report
- October 2021
- 39 Pages
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Report
- November 2023
- 92 Pages
Global
From €3500EUR$4,240USD£3,091GBP
- Report
- July 2023
- 99 Pages
Global
From €3500EUR$4,240USD£3,091GBP
- Report
- July 2023
- 108 Pages
Global
From €3500EUR$4,240USD£3,091GBP
- Report
- October 2024
- 84 Pages
Global
From €3500EUR$4,240USD£3,091GBP
- Report
- October 2024
- 104 Pages
Global
From €3500EUR$4,240USD£3,091GBP
- Report
- October 2024
- 93 Pages
Global
From €3500EUR$4,240USD£3,091GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more